For a number of rare adrenal disorders, some of which are life threatening in childhood, laboratories need access to specialist endocrine investigations. Measurements of hormones in blood samples may be diagnostic in some cases but not all of the requisite steroid hormone assays are available. Multiple plasma steroid measurements may be required to prove the nature of a steroid biosynthetic disorder but in newborn children immunoassays, performed without prior solvent extraction, can be misleading. A urine steroid profile by gas chromatography coupled with mass spectrometry examines many steroid metabolites simultaneously and provides specific diagnostic information. A urine steroid profile can provide precise information of the secretory nature of tumours and causes of virilization, salt loss and hypertension often from a spot urine sample rather than a 24 h collection. However, a steroid profile is not helpful in making a diagnosis in neonatal genetic males with poorly developed genitalia.
SUMMARY. For a number of rare adrenal disorders, some of which are life threatening in childhood, laboratories need access to specialist endocrine investigations. Measurements of hormones in blood samples may be diagnostic in some cases but not all of the requisite steroid hormone assays are available. Multiple plasma steroid measurements may be required to prove the nature of a steroid biosynthetic disorder but in newborn children immunoassays, performed without prior solvent extraction, can be misleading. A urine steroid profile by gas chromatography coupled with mass spectrometry examines many steroid metabolites simultaneously and provides specific diagnostic information. A urine steroid profile can provide precise information of the secretory nature of tumours and causes of virilization, salt loss and hypertension often from a spot urine sample rather than a 24 h collection. However, a steroid profile is not helpful in making a diagnosis in neonatal genetic males with poorly developed genitalia.
Additional key phrases: gas chromatography; congenital adrenal hyperplasia; electrolyte balance; adrenal function Adrenal and gonadal steroid hormone synthesis requires the action of several enzymes on stored cholesteryl esters and the stimulus of specific trophic factors from the pituitary (adrenocorticotrophin, luteinizing hormone, follicle stimulating hormone) or elsewhere (renin/angiotensin). Cortisol, aldosterone and sex steroids are the normal products of the adrenal cortex, but during the course of their production a number of intermediates will be secreted from the glands and circulate in blood at measurable concentrations ( Fig. I ). Hormones in blood are normally quantified by immunological methods. The assays in current use for cortisol, progesterone, oestradiol and testosterone are only occasionally subject to interference in adults but the variable nature of the hormonal milieu in children makes assay interference more of a problem particularly in the neonate. During childhood, the rates at which steroid hormones are produced vary with age and development (Table 1) . Fetal adrenal zone steroids (3fJ-hydroxy-5-ene steroid sulphates) are particularly important and high plasma levels of steroid sulphates are a cause of assay interference in the newborn ( Table 2) . One important example is the measurement of 17-hydroxyprogesterone in the newborn, some direct assays for which also detect 17-hydroxypregnenolone sulphate.' There are other metabolic features unique to the newborn: plasma cortisol concentrations rarely exceed 300 nmol/L and the molar cortisol to cortisone ratio may vary from less than O' 3 in the neonate to greater than 2·0 in children older than 6 months. At any time a number of metabolites of each hormone are found in the urine (Table 3) , most being reduced products of the circulating steroid. In the newborn, there can be many additional hydroxylated metabolites.
The investigation of a patient with a possible defect in steroid biosynthesis or metabolism will require the measurement of several hormones; single hormone measurements in blood are rarely useful. Because of the rarity of requests for certain steroids, a non-specialist laboratory should not be tempted to use an immunoassay which has not been validated for paediatric samples. Information will also be needed on the status of the appropriate trophic hormones. Provocative testing may be required. In some cases, urine steroid analysis will provide data which is complementary to measurements of hormones in blood. Other relevant factors which can affect the choice of investigations wiIl be discussed in the context of specific clinical problems.
DEFINITION
A steroid profile is the name given to an analysis of urinary steroids by capillary column gas chromatography (GC). The technique most frequently used involves a temperature-programmed separation over about I h. A pattern of urinary steroids, eluted from the GC, different from normal in its overall appearance reflects unusual steroid production. The absence of particular steroids and the identification of abnormal steroids can be attributed to defective enzymes, and a urine steroid profile is useful for defining adrenal biosynthetic, developmental and oncological problems. A biochemical diagnosis of one of the synthetic defects requires demonstration of high levels of substrate for the defective enzyme. Since diagnostic information is obtained in many instances from the patterns and ratios of metabolites, it is not always (Table 4) The distress to parents is immense when the sex of their child is not obvious at birth. Chromosome analysis is needed to confirm the genotype of the child but abdominal ultrasound will give a good indication of gonadal sex by revealing the presence or absence of a uterus. A definitive diagnosis requires hormone studies, the results of which are required as quickly as possible: the sooner these are available, the earlier the clinician can discuss with the parents the sex for rearing the child, as well as the risks of recurrence and treatment.
The virilized female infant
The commonest cause of ambiguous genitalia in the newborn is congenital adrenal hyperplasia (CAH) due to deficiency of CYP21, but defects of CYPIIBI and 3P-hydroxysteroid dehydrogenase (HSD3B2) are also seen. Most girls with ambiguous genitalia have low aldosterone production. Hyperkalaemia can often be detected near the end of the first week, before hyponatraemia becomes evident. Hypertension is a feature of CYPIIBI deficiency in an older patient but high blood pressure is rarely found in affected neonates. The CYP21 defect is by far the commonest form of CAH and it is reasonable in all cases of ambiguous genitalia to request analysis of serum for 17-0HP provided that certain factors are considered. The plasma 17-0HP concentration will be clearly raised above normal by the second day of life and the results are typically 300-800 nmol/L: unaffected neonatal levels are less than 15 nmol/L, Many stressed normal newborn children can have concentrations of 17-0HP in the blood as high as 100 nmol/L, 3 Placental progesterone and its products are still present in the circulation which can interfere in the immunoassay for 17-0HP. In a sick child or preterm infant, 17-0HP assays still tend to lack diagnostic sensitivity many days after birth because of inteference in the assay by fetal adrenal zone steroid sulphates." 17-0HP can also be elevated in CAH due to HSD3B2 and CYPIIBI defects because isoenzymes of HSD3B expressed in other tissues can produce more potent androgens from dehydroepiandrosterone (DHA) and can oxidize 17-hydroxypregnenolone to 17-0HP, respectively, which can thus be measured at high concentrations and confuse the diagnosis. Premature babies may show signs of virilization due only to the persistence of fetal adrenal androgen production which is revealed in a steroid profile. CAH is excluded in nearly all such pre term infants by finding a normal pattern of urine steroids Ann Clin Biochem 1997: 34 produced by the zona fasciculata of the adrenal cortex.
CAH requires life-long treatment and a definitive diagnosis by urine steroid profile is warranted. To misdiagnose CYP21 deficiency for HSD3B2 deficiency sets the scene for major confusion at puberty. Accurate diagnosis is also important in order to direct appropriate genetic studies for counselling and prenatal diagnosis of any subsequent pregnancy bearing in mind that fetal virilization can be prevented by synthetic steroid (dexamethasone) administration to the mother.'
The steroid profile in neonates with 21hydroxylase deficiency is more complex than in an older patient but a consistent diagnostic pattern of steroids in urine is seen from the third day of life. 6 • 7 Many unusual derivatives of 17-OHP are recognized in newborn urine, several products being hydroxylated at C-15.6-8 The components of the profile need mass spectroscopy (MS) to confirm the identities of the steroids. The statement in textbooks that urine assays are not reliable is false; it was based on the fact that pregnanetriol (PT), which was the accepted marker for 21-hydroxylase deficiency, could not be shown to be excreted in excess amounts in the neonatal period. The urine steroid profile from patients older than 6 months of age has three major peaks (l7-hydroxypregnanolone, PT and l l-oxo-pregnanetriol)".
CAH due to CYPIIBI deficiency is unusual in UK and USA (5% of all CAH cases). Plasma concentrations of l l-deoxycortisol above 60 nrnol/L (often 300-1000 nmol/L) support the diagnosis. In the normal neonate l l-deoxycortisol concentrations are less than 10nmol/L. In some cases referred to this SAS laboratory previous results have indicated that both plasma 17-0HP and 11-deoxycortisol concentrations were raised. When such doubt has arisen, a urine steroid profile showed a diagnostic pattern with tetrahydro-ll-deoxycortisol (THS) clearly elevated, along with 6-hydroxy-THS (a typical neonatal steroid metabolite)." The raised plasma 17-0HP was not supported by elevation of those metabolites in the urine. It is possible that products of l l-deoxycortisol may interfere in some plasma 17-0HP assays.
A plasma concentration of DHA sulphate (DHAS) above 5/lmol/L which suppresses with dexamethasone supports a diagnosis of a defect in HSD3B2 but, high concentrations are seen with adrenal tumours which may actually be more common than that enzyme defect. In the case of CAH due to deficiency of HSD3B2 the enzyme activity appears to be completely absent so that plasma cortisol and aldosterone are low. Plasma assays for 17-0HP may give misleading high results. Few laboratories run assays for 17-hydroxypregnenolone, a substrate for the HSD3B2 enzyme, which would be present in plasma at high concentration in affected cases. In a urine steroid profile, cortisol metabolites will be very low or absent in relation to the excretion rates of 3fJ-hydroxy-5-ene steroids (DHA and pregnenolone). A reliable 24h urine collection after the third day would be needed in order to compare the 3fJ-hydroxy-5-ene steroid excretion rates against normal ranges. These patients rapidly become very ill due to electrolyte disturbances and treatment with steroids makes early diagnosis difficult. At a later stage, a urine steroid profile gives clear indications for the HSD3B2 defect (raised DHAS, 16-hydroxy-DHAS and pregenenetriol). If hydrocortisone treatment cannot be withdrawn, it should be switched to dexamethasone (which does not show up in the urine steroid profile assay), and the child is then given three daily injections of long-acting Synacthen before a urine specimen for profile analysis is taken.
The poorly virilized male infant
The clinician needs to know if such a boy can be raised as a male. If the child has a defect in testosterone production, this can be treated, but if there is resistance to the action of androgen then masculinization will never be achieved. The investigation of the poorly virilized male infant often requires the help of the specialist laboratory and a paediatric endocrinologist who is familiar with the nature and abnormal changes in the function of the hypothalamic-pituitary-gonadal axis in childhood and, particularly, in the first week and months of life.!" Gonadal defects of testosterone production are best investigated using blood hormone measurements before and after gonadal stimulation with luteinizing hormone (usually given as chorionic gonadotrophin). Urine steroid profile analysis in the newborn male with micropenis and/or hypospadias is not helpful except when the low androgen production is the result of a defect in cortisol synthesis (e.g. CYPI7 or HSD3B2 deficiency) or lipoid adrenal hyperplasia. A male with CAH due to HSD3B2 deficiency will have poorly developed genitalia and develop a salt-losing state. CAH due to CYPI7 deficiency has been reported in one newborn male with ambiguous genitalia.'! As corticosterone assays are not generally available, a urine steroid profile which shows evidence of corticosterone metabolites in excess supports a diagnosis of CYP17 deficiency. Hypertension in childhood with this defect is rare, and the majority of cases reported have been adults presenting with amenorrhoea and infertility.F Salt-losing states ( Table 5) A child with a salt-losing state will present as an emergency. In a young male infant with hyponatraemia, hyperkalaemia and renal salt wasting, CAH due to 21-hydroxylase deficiency is a likely cause. Concentrations of l7-0HP in blood are elevated in all sick infants and results for 17-0HP up to 150 nmol/L are insufficient to accept as proof of CAH due to CYP2l deficiency. The salt loss is due to aldosterone deficiency but this is also a feature of congenital adrenal hypoplasia and of CAH due to HSD3B2 or CYPllA deficiency. The differentiation of lipoid adrenal hyperplasia. The latter condition is associated with low levels of all steroids even after continued adrenal stimulation. Some cases of adrenal hypoplasia show a fetal adrenal secretory pattern of urine steroids. These children require rapid treatment which has priority over early diagnosis. Some patients with adrenal hypoplasia will later show pubertal failure which reflects gene deletion of related parts of the X-chromosome which influences both adrenal development and the gene for gonadotrophin-releasing hormone. \3 An infant failing to thrive may have poor sodium retention due to defective aldosterone synthesis or a mineralocorticoid resistance (receptor defect). These clinical problems are more difficult to diagnose if the child is in salt balance, particularly if cortisol has been given, as the milligram amounts of exogenous steroid metabolites will mask the increased mineralocorticoid metabolites. Fludrocortisone (a mineralocorticoid) at the usual doses of 150j.lg/m 2 / 24 h is insufficient to be detectable in the urine steroid assay. High plasma renin activity and high plasma aldosterone concentrations for age are supportive evidence for pseudohypoaldosteronism. Treatment with mineralocorticoid will fail to restore both salt balance and suppress renin activity. Diagnosis of defective aldosterone production by plasma hormone assays is difficult because assays for the relevant intermediates (corticosterone, I8-hydroxycorticosterone) are not generally available.
Disorders of aldosterone synthesis are distinguishable by characteristic urine steroid profiles. Excess of corticosterone without or with a surfeit of I8-hydroxycorticosterone metabolite (l8-hydroxy-tetrahydro-ll-dehydrocorticosterone, 18hydroxy-THA) suggests defects in one of two late steps of aldosterone biosynthesis (l8-hydroxylase or 18-oxidase, respectively). When tetrahydroaldosterone is detected along with 18-hydroxy-THA, these reflect high mineralocorticoid production, consistent with a poor response to excess mineralocorticoid such as in pseudo hypoaldosteronism.l" Adrenarche and virilization ( Table 6) An increase in adrenal androgen production is associated with the appearance of pubic hair. If this happens in advance of other changes of puberty it can be alarming for the child and the parents. There is often an increase in growth rate and sometimes a change in the body odour. The cause is usually DHAS levels above normal in blood; suppressibility with dexamethasone is consistent with adrenarche. If DHAS is normal, other causes of virilization in girls or precocious puberty in boys need to be excluded and a steroid profile has some advantages over repeated blood hormone measurements in the diagnosis of adrenal causes.
Adrenal tumours can secrete DHAS and/or a number of different androgens which explain clinical signs (e.g. c1itoromegaly). Several patterns of urine steroids have been seen with adrenal tumours. The commonest is due to a tumour secreting DHAS,lS and high levels of this steroid in the blood do not suppress with dexamethasone. As the tumour may produce both androgens and cortisol the child will usually be obese. Tumours secreting pregnenolone are rare, but many secreting l lji-hydroxyandrostenedione have been seenIS and this may be detected as an increase in the plasma androstenedione concentration in immunoassay by cross-reaction. Assays for l Iji-hydroxyandrostenedione and pregnenolone are not generally available. If unusual steroids are being produced, a urinary steroid profile is the best approach for diagnosis, and subsequent measurement will be useful for detecting recurrence unless a blood test reflecting renewed abnormal hormone production is available. Testicular tumours and ovarian cysts can be the source of raised 17-hydroxyprogesterone production, but the urinary steroid profiles are different from the patterns seen in CAH.
Early growth of pubic hair with or without acne and/or hirsutism in either sex may reflect late presentation of classical CAH or indicate a late-onset (LOCAH), non-classical form. These are due to different genetic events in the CYP21 gene which lead to enzymes of differing activity." A heterozygote for CAH may also present with these clinical signs. Measurements of 17-0HP before and after ACTH stimulation (Synacthen test) do not always produce results which are distinguishable from normal.!? even in the case of a child who is a carrier for CAH due to 21-hydroxylase deficiency. A basal plasma 17-0HP below 6 nmol/L makes LOCAH unlikely. A 17-0HP above 30 nrnol/L after ACTH stimulation is supportive of LOCAH. Heterozygotes for CAH can have 17-0HP concentrations which are normal or in the range typical of LOCAH.1M If 17-0HP is normal, one of the other steroidogenic enzymes may be affected. Further hormones will have to be measured to confirm those defects. A urine steroid profile is a useful general test which is not greatly different in cost from multiple hormone measurements in several blood samples during a stimulation test. 21-deoxysteroid metabolites are sufficiently raised in random urine samples in patients with LOCAH to discriminate from normal without the need for a stimulation test. \9 A phenotypic girl with c1itoromegaly and body changes towards a male habitus around the time of puberty may be a genetic male child with a defect of androgen production showing clinical response to gonadal androgen production. A male with 51X-reductase deficiency may not have virilized in utero because of failure to produce dihydrotestosterone. At puberty, however, the increase in testosterone production from the gonads influences development. Likewise, a child with 17-ketosteroid reductase (HSD 17B3-by analogy with nomenclature used elsewhere) deficiency will show clinical signs in response to the increased gonadal androstenedione production at puberty.
If 51X-reductase deficiency is suspected around the time of puberty, the ratios of adrenal androgen and cortisol metabolites (low androsterone to aetiocholanolone and 51X-THF to THF ratios) reflect the defect. In the younger child older than 6 months of age, 51X-reductase deficiency can be inferred only from the low 51X to 5fJ-THF ratio in the urine because there is insufficient androgen in the urine of the prepubertal infant." Before 6 months of age cortisol metabolites appear as products of cortisone for which there is no 51X-reduced urinary metabolite to assist with the diagnosis and measurements of plasma testosterone and 5dihydrotestosterone before and after HCG are needed.
HSD 17B3 deficiency also usually presents for the first time at puberty." The ratio of androsterone to aetiocholanolone is raised in patients with 17-ketosteroid reductase deficiency, reflecting the metabolism of androstenedione to the 51X-reduced androsterone.
Adrenal suppression
The commonest situation where the adrenal function of a child is suppressed is when steroids have been administered for asthma, but blood hormone tests do not always provide proof of this. Inhaled steroids such as beclomethasone diproporionate (Becotide) at doses above 400 J1g/m 2 /24 h will suppress cortisol secretion during the night but only at high doses will the 0800 h blood cortisol be suppressed below the expected normal range (200-800 nmol/L), Peak cortisol levels can vary from 0600 h to 1000 h even in normal subjects. Plasma cortisol levels in the asthmatic patient can be low during the night (when blood samples are taken at 15 min intervals throughout the night) but normal at 0800 h. There is a dose-related suppression of the total cortisol metabolites in urine.F From a 24-h urine collection a sum of the excretion rates of individual cortisol metabolites in the urine steroid profile can be produced and these results come close to cortisol production rate determined recently using stable isotope dilution techniques. The urine steroid analysis is therefore more helpful than other investigations of such children. For example, measurements of cortisol in plasma at midnight and 0800 h or after a standard Synacthen test will almost certainly be normal even though much of the pulsatile adrenal activity will be lost during the night.P A 24-h urine free cortisol measurement will often be requested, but this test is designed for evaluating excess cortisol production. Adrenal androgen production will often be low in children with asthma but this is a function of the disease rather than the treatment.
Cushing's syndrome Excess cortisol production in children does not always lead to the same clinical picture as in adults although many affected children are obese. For example, the full-moon shaped face and buffalo hump often seen in the adult patient presenting with Cushing's syndrome may not be so obvious in a child. The growth rate of the child with Cushing's syndrome may be advanced or suppressed depending on the spectrum of steroids produced. Measurement of 24-h urine free cortisol is a good screening test and if it is raised suppressibility with dexamethasone can be investigated using doses of steroid adjusted to the body size. Dexamethasone (0,3 mg/m-) taken by mouth at night normally suppresses plasma cortisol at 0800 h. 24 Cortisol and ACTH measurements at midnight and 0800 h are useful to show loss of the normal circadian rhythm.
Most cases of Cushing's syndrome in childhood are due to pituitary adenomas (Cushing's diseasej." but an adrenal tumour may secrete other steroids besides cortisol and a urine steroid profile will detect excess hormone products. An additional advantage is that in the event of incomplete tumour resection, the steroid pattern can be followed to detect recurrence.
In the rare case of an ectopic ACTH-secreting tumour the total steroid output is much higher than in cases of Cushing's disease or adrenal tumour." There is also an increase in the ratio of cortisol to cortisone metabolites as cortisol production increases and an increase in the ratio of allo-tetrahydrocortisol (51)(-THF) to tetrahydrocortisol (THF).27
Hypertension (Table 7) Hypertension in children is more likely to be due to renal than to adrenal disease, but if there is hypokalaemia and plasma renin activity is low, the presence of mineralocorticoid-induced hypertension is suggested. An aldosteronesecreting tumour is exceptional in childhood and would be confirmed by finding elevated plasma aldosterone concentrations for age although postural studies, which help in the diagnosis in an adult, are difficult to perform in younger children.
Severe hypertension in childhood can be associated with a defect of the enzyme Ilflhydroxysteroid dehydrogenase which normally converts cortisol to inactive cortisone. The defect was lethal in one young child-" and many cases may have been missed. The llfl-hydroxysteroid dehydrogenase may protect the mineralocorticoid receptor from the action of cortisol. Assays for cortisone are not readily available. The urine steroid profile of a patient with a defect of this enzyme shows very little tetrahydrocortisone (THE) and a relative excess of tetrahydrocortisol (THF)29 which is diagnostic of the disorder which is often called 'apparent mineralocorticoid excess' (AME) syndrome.
Hypertension and primary amenorrhoea are the presenting features of CAH due to 17hydroxylase deficiency. Most of the patients have been reared as normal females and only two cases in the literature have been detected in childhood'I-", Corticosterone metabolites are clearly elevated and adrenal androgen and cortisol metabolites are absent from the urine steroid profile", Dexamethasone suppressible hyperaldosteronism is characterized by high production rates of 18-hydroxycortisol. Since there are few plasma assays for this steroid, a better approach is to use a urine profile which will pick up 18hydroxycortisol as well as 18-oxo-cortisol. The genetic basis of this disorder has now been defined. The production of a chimaeric gene with the ACTH regulatory elements of CYPIIBI and the 18-hydroxylase activity of CYPIIB2 account for the abnormal steroid production pattern and the suppressibility with dexamethasone.P
PROBLEMS WITH URINE STEROID PROFILE ANALYSIS IN CHILDREN
The biggest problem in using quantitative steroid profile analysis to assist paediatric diagnoses is the reliability of a 24 h urine collection. In many of the examples described above, the diagnosis is aided by finding abnormal proportions of metabolites so that a spot or random urine collection will be helpful in most cases of biosynthetic defects. In very young babies, collection bags can be used, although there may be problems using bags when the child has ambiguous genitalia and urine is not discharged normally. A cot can be cheaply made such that the baby lies on a suspended nylon sheet and the urine passes through this to be channelled to a collection point. Hospital wards are usually warm and the baby needs little cover to reduce heat loss during the collection period.
In young patients with suspected adrenal disease it is often essential that the child be treated before investigations can be completed. Once the child is on treatment, there will be reluctance to withdraw medication. In some cases, an adrenal stimulation test can be performed without compromising the treatment. By switching a child needing steroids to dexamethasone (the metabolites of which do not show up in the urine steroid profile), and injecting a depot preparation of Synacthen before urine collection, the patient can be controlled whilst stimulating the adrenal to secrete large amounts of steroids which are excreted in the urine. Urine steroid analysis will frequently reveal adrenal steroid biosynthetic abnormalities.
For some of the salt-losing states it may still be necessary to perform the investigations when the patient is salt-depleted but this will need an opportunistic or planned hospital admission.
For the non-steroid specialist there are difficulties in interpretation of the steroid nomenclature. Also for each hormone several urine metabolites will need to be considered. The data from patients need to be looked at in different ways, and it is not possible to quote a single reference range. Reference ranges for excretion rates vary considerably according to age, sex and body-size and interpretation of results in the light of these variables must be provided by the specialist laboratory because many endocrine problems in children affect growth and body size. In some instances, the ratio of metabolites will be important. The conclusion from the results should be clear and, where necessary, suggest realistic further investigations for confirmation of the suspected diagnosis.
Note Further advances in our knowledge have come from recent papers in the molecular biology area. Although several papers have suggested, from biochemical studies, a late-onset form of HSD3B2 deficiency, this explanation is probably not correct because the gene sequences have been normal in a number of patients." The sequence of the CYPIIA gene and the aldosterone receptor gene were found to be normal in a number of patients with, respectively, lipoid adrenal hyperplasia and pseudohypoaldosteronism. This made defects of cholesterol side-chain cleavage (desmolase) and aldosterone resistance unlikely as the causes of these conditions. A new gene coding for a steroidogenic acute regulatory (StAR) protein was characterized and mutations have been found in the genes of patients with lipoid adrenal hyperplasia.r'r'! This protein is normally important for the transport of cholesterol into the mitochondria. The disease locus for pseudohypoaldosteronism has been mapped to chromosome 16pI2.2-13.11 and to 12pI3.I-pter in different families. The two chromosomal regions harbour genes for subunits of the amiloridesensitive epithelial sodium transport channel and defects can lie in either of the loci. 36 • 37 
